NEW YORK (GenomeWeb News) — DNAVision has received Good Laboratory Practices compliance certification for its lab from the Belgium Scientific Institute of Public Health.
The certification covers the lab’s pharmacogenomic and toxicogenomic research services for medicinal compounds.
The Brussels-based company said Tuesday that the clearance from the Belgian government makes it the first lab in Europe to receive clearance under GLP principles of the Organization for Economic Co-operation and Development and European Union.
DNAVision, a spin-off from the University of Brussels and the Institute of Pathology and Genetics, offers SNP genotyping, sequencing, and expression profiling services.